Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,510
datasets available to search
ShareScore release 0.9.0
Dataset results
1,510 results for “Liver disease”
A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)
ClinicalTrials.gov study NCT04944992. IPD Sharing: YES. Countries: 16. Publications: 1.
A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH
ClinicalTrials.gov study NCT04048135. IPD Sharing: UNDECIDED. Countries: 2. Publications: 3.
Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT03459079. IPD Sharing: NO. Countries: 1. Publications: 10.
Introducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD)
ClinicalTrials.gov study NCT03540771. IPD Sharing: NO. Countries: 1. Publications: 5.
Insulin Resistance in Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT00252499. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
ClinicalTrials.gov study NCT01679197. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT04031729. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 2b Study of Icosabutate in Fatty Liver Disease
ClinicalTrials.gov study NCT04052516. IPD Sharing: NO. Countries: 2. Publications: 1.
Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant
ClinicalTrials.gov study NCT03862807. IPD Sharing: YES. Countries: 7. Publications: 3.
Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
ClinicalTrials.gov study NCT00078403. IPD Sharing: Not stated. Countries: 2. Publications: 12.
Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT05697991. IPD Sharing: NO. Countries: 1. Publications: 1.
Chinese CLIF-C Acute-on-Chronic Liver Disease and Liver Failure Study
ClinicalTrials.gov study NCT02457637. IPD Sharing: UNDECIDED. Countries: 1. Publications: 19.
Intermittent Fasting and Metabolic Dysfunction Associated Fatty Liver Disease
ClinicalTrials.gov study NCT06664684. IPD Sharing: NO. Countries: 1. Publications: 6.
The Impact of Different Exercise Modes on Bile Acid Levels and Liver Function in Patients With Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT06338449. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Pasireotide LAR in Severe Polycystic Liver Disease
ClinicalTrials.gov study NCT01670110. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver Disease
ClinicalTrials.gov study NCT05554224. IPD Sharing: YES. Countries: 1. Publications: 1.
Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant
ClinicalTrials.gov study NCT01938430. IPD Sharing: YES. Countries: 1. Publications: 2.
Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT07294963. IPD Sharing: YES. Countries: 1. Publications: 4.
Safety, Tolerability, and Efficacy of Saroglitazar Mg 4 mg in Liver Transplant Recipients With Nonalcoholic Fatty Liver Disease (NAFLD)
ClinicalTrials.gov study NCT03639623. IPD Sharing: NO. Countries: 1. Publications: 2.
Incidence of Liver Disease-Related Outcomes in People With HIV
ClinicalTrials.gov study NCT06940375. IPD Sharing: NO. Countries: 1. Publications: 8.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.